Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Planning and Dissemination Grant - Institute Community Support

Ottawa Hospital Research Institute

$10,000.00

A national platform to study inflammatory acute lung injury

EF 2019-20

Résumé
The acute respiratory distress syndrome (ARDS) is a devastating inflammatory clinical condition in the intensive care unit. Serious infection often causes ARDS and it results in death of up to 60% of people who develop it. There are currently limited treatments for this disease, and ongoing research is the only way to discover new treatments for ARDS. Using animals to perform research on ARDS is currently the best way to represent the complex processes that underlie it. Many researchers across Canada use 'animal models' of this disease in order to study it. One aspect which makes this research difficult is the lack of standardized procedures to run these studies and analyze the results. We propose a meeting to help standardize some of the ways we study this disease. This will establish a Canadian group of researchers that can test therapies in a number of labs at the same time. We believe this will test the "reproducibility" of findings, and increase confidence in the results of these studies. This type of collaborative approach is very common in clinical trials with patients, but it has not been established in laboratory research. In fact, the study we will begin to plan at this meeting will be Canada's first multicenter preclinical study. Our meeting will bring together a diverse group of scientists, trainees, and veterinarians needed to make this type of collaborative work possible. Ultimately, we believe this will lead to results from animal research being 'translated' more readily to clinical therapies for patients with ARDS.
Programme
Planning and Dissemination Grant - Institute Community Support
Emplacement
Ontario, Canada
Type de bénéficiaire
Other
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
412374
Name
Stewart Duncan J
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Planning and Dissemination - III
Projecttitle
A national platform to study inflammatory acute lung injury
Programtype2
Miscellaneous Programs
Orgnameinp2
Ottawa Hospital Research Institute
Cihramount2
$10,000
Cihrequipment2
$0
Programname2
Planning and Dissemination Grant - Institute Community Support
Keyworddelim
Acute Lung Injury; Acute Respiratory Distress Syndrome; Inflammation; Preclinical; Reproducibility; Translational Science
Abstract
The acute respiratory distress syndrome (ARDS) is a devastating inflammatory clinical condition in the intensive care unit. Serious infection often causes ARDS and it results in death of up to 60% of people who develop it. There are currently limited treatments for this disease, and ongoing research is the only way to discover new treatments for ARDS. Using animals to perform research on ARDS is currently the best way to represent the complex processes that underlie it. Many researchers across Canada use 'animal models' of this disease in order to study it. One aspect which makes this research difficult is the lack of standardized procedures to run these studies and analyze the results. We propose a meeting to help standardize some of the ways we study this disease. This will establish a Canadian group of researchers that can test therapies in a number of labs at the same time. We believe this will test the "reproducibility" of findings, and increase confidence in the results of these studies. This type of collaborative approach is very common in clinical trials with patients, but it has not been established in laboratory research. In fact, the study we will begin to plan at this meeting will be Canada's first multicenter preclinical study. Our meeting will bring together a diverse group of scientists, trainees, and veterinarians needed to make this type of collaborative work possible. Ultimately, we believe this will lead to results from animal research being 'translated' more readily to clinical therapies for patients with ARDS.
Competitiondate
201909
Approvedterm2
1 yr 0 mth
Pinamesdelim
Stewart, Duncan J; Fergusson, Dean A; Lalu, Manoj M
Approvedterm
1 an 0 mois
Cihrcontribution2
Inst of Infection & Immunity~ $10,000~ $0~